Pharmaxis's Bronchitol succeeds in Phase II cystic fibrosis study
This article was originally published in Scrip
Executive Summary
Pharmaxis's investigational drug Bronchitol, a dry-powder formulation of mannitol for inhalation, has shown benefit in a Phase II trial in cystic fibrosis.